Kratom First FDA Study Suggests Capsules Are Safe At High Dosages

The FDA research is intended to help fill a void in dosage knowledge
Kratom leaves appear safe even at high doses when taken in capsule form, US regulators found in their first preliminary study of the popular botanical compound that they’ve targeted as a potential public health threat.
The US Food and Drug Administration research is intended to help fill a void surrounding the compound that’s been used for centuries in Southeast Asia, where people chew the leaves to get their mind-altering effects. Important questions remain about its impact in drinks and concentrates — more common in the US — which contain higher levels of kratom and could pose greater danger to consumers.
To Read The Rest Of This Article On Bloomberg, Click Here
